Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).
Yang LiChangkun ZhuHongyu XieYaxia ChenWei-Guo LvXing XieXinyu WangPublished in: Journal of gynecologic oncology (2023)
ClinicalTrials.gov Identifier: NCT05179447.